Clinical Trial Update: SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and Over [Phase 4]

View source ↗

Summary

A completed Phase 4 pharmacokinetics study evaluating the fixed-dose HIV regimen abacavir/lamivudine/dolutegravir in patients aged 60 years and older.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Triumeq (dolutegravir/abacavir/lamivudine)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 4 | Status: COMPLETED